` 0D1W (Biophytis SA) vs DAX Index Comparison - Alpha Spread

0D1W
vs
D
DAX Index

Over the past 12 months, 0D1W has underperformed DAX Index, delivering a return of -91% compared to the DAX Index's +10% growth.

Stocks Performance
0D1W vs DAX Index

Loading
0D1W
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
0D1W vs DAX Index

Loading
0D1W
DAX Index
Difference
www.alphaspread.com

Performance By Year
0D1W vs DAX Index

Loading
0D1W
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Biophytis SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Biophytis SA
Glance View

Market Cap
1.6m EUR
Industry
Biotechnology

Biophytis SA is a holding company. The company is headquartered in Paris, Ile-De-France and currently employs 24 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

0D1W Intrinsic Value
Not Available
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett